Clinical Trial Update: A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial) [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial (ALFA Trial) evaluating the angiotensin receptor blocker fimasartan for aortic stenosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• Fimasartan (fimasartan)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Critical Stenosis of Aortic Valve | Phase 4 | Status: UNKNOWN